Commentary: Balancing Upfront Surgery and Neoadjuvant Therapy in Clinically Node-Negative T2–3 Esophageal Squamous Cell Carcinoma
Journal of Chest Surgery · 05.05.2026 · 59 (3) · 127-128
DOI: 10.5090/jcs.26.073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chest Surgery, erschienen am 05.05.2026. Verfasst von Jae Hyun Jeon. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongna…. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
ORCID-Profile: Jae Hyun Jeon
Zitieren
APA
Jeon, J. H. (2026). Commentary: Balancing Upfront Surgery and Neoadjuvant Therapy in Clinically Node-Negative T2–3 Esophageal Squamous Cell Carcinoma. Journal of Chest Surgery, 59(3), 127-128. https://doi.org/10.5090/jcs.26.073
Vancouver
Jeon JH. Commentary: Balancing Upfront Surgery and Neoadjuvant Therapy in Clinically Node-Negative T2–3 Esophageal Squamous Cell Carcinoma. Journal of Chest Surgery. 2026;59(3):127-128. doi:10.5090/jcs.26.073
BibTeX
@article{Jeon2026,
author = {Jeon, Jae Hyun},
title = {Commentary: Balancing Upfront Surgery and Neoadjuvant Therapy in Clinically Node-Negative T2–3 Esophageal Squamous Cell Carcinoma},
journal = {Journal of Chest Surgery},
year = {2026},
volume = {59},
number = {3},
pages = {127--128},
doi = {10.5090/jcs.26.073}
}
EUVIMED